The leadership team of ACELYRIN continues to express strong assurance in the strategic merger with Alumis (ALMS, Financial), considering it the most beneficial route for enhancing shareholder value. Highlighting the significance of the merger, ACELYRIN's Board Chair, alongside the independent transaction committee, has emphasized that this proposal is designed to deliver maximum value to ACELYRIN's investors.
This merger agreement with Alumis is a result of a thorough and competitive evaluation conducted by the ACELYRIN Board. The negotiation has led to an improved agreement, increasing the ownership stake for ACELYRIN shareholders in the merged entity. As the date for the Special Meeting approaches, ACELYRIN urges its shareholders to vote in favor of the merger to secure their investment's potential growth.
In a unified decision, ACELYRIN's Board of disinterested and independent members strongly recommends that stockholders support the merger with Alumis (ALMS, Financial), underscoring its strategic importance and prospective financial benefits.
